About Spentose
Spentose is a Healthcare company based in Mumbai (India) founded in 2005. It develops and manufactures pharmaceutical APIs and finished dosages for international markets. It operates on a B2B model. The company has 409 employees. Its Indian entity Swati Spentose Private Limited reported revenue of ₹206 Cr. Spentose offers products and services including APIs and Finished Dosage. Its focus areas include Pharmaceuticals, Finished Dosage, Formulations and API Manufacturing. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
SWATI Spentose is a global pharmaceutical company headquartered in Mumbai, India, focused on research and innovation in drug development. They produce active pharmaceutical ingredients (APIs) and finished formulations, addressing neglected diseases and serving over 70 countries. With manufacturing facilities in Vapi, Gujarat, they emphasize quality, compliance, and cost-effective solutions through advanced production processes.
- Headquarters Mumbai, India
- Employees 409
- SectorsHealthcare
- Email••••••••
- Website spentose.com
- Social LinkedIn
- Legal Name Swati Spentose Private Limited
- Date of Incorporation 14 Dec, 2005
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹206 Cr
FY 2024 · +11% YoY
- Net Profit₹29.94 Cr
FY 2024 · 15% margin
- EBITDA₹48.09 Cr
FY 2024 · 23% margin
- Employee Count409
Associated legal entities of Spentose
Spentose operates through Swati Spentose Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Swati Spentose Private Limited CIN U51909MH2005PTC158176 | Active | 14 Dec 2005 | Mumbai, Maharashtra | ₹206 Cr | 409 | 3 | View details |
Products & Services of Spentose
Spentose offers a comprehensive portfolio of products and services, including APIs and Finished Dosage.
Active ingredients for generic drug manufacturing and research
Ready-to-use formulations for therapeutic applications
Board of directors of Swati Spentose Private Limited (Spentose)
Swati Spentose Private Limited is the primary company behind Spentose. The board of Swati Spentose Private Limited currently have 3 directors; the longest-serving is Vishal Narayanprasad Jajodia, appointed in 2005. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vishal Narayanprasad Jajodia DIN 00367209 | Director | 20 Dec 2005 | 20 yrs 10 mo | Swati Spentose Private Limited |
| Manojkumar Rinwa DIN 10216457 | Director | 07 Aug 2023 | 3 yrs 2 mo | Swati Spentose Private Limited |
| Pankaj Ram Sharma DIN 05243001 | Director | 07 Aug 2023 | 3 yrs 2 mo | Swati Spentose Private Limited |
People of Spentose
18 people are tracked at Spentose (6 in leadership, 12 in team); the tracked headcount is 409.
| Name | Role | Group |
|---|---|---|
Swati V. Jajodia | CEO | Leadership |
| Managing Director | Leadership | |
Subhrajit Saha | Head Sales & Marketing | Leadership |
Neha Jain | International Finance Head | Leadership |
P.n Rao | Quality HEAD | Leadership |
Francis-Xavier Barretto | Chief Scientific Officer | Leadership |
Neelam Mistry | BD Manager (formulation Division) At Swati Spentose Pvt. Ltd | Team |
Ajay Mishra | Quality Control Manager | Team |
Vivek Bhojwani | Senior Manager - Operations And Company Affairs | Team |
Mudassar Tailor | International Business Development | Team |
Shreya Mishra | Regulatory Affairs And Business Development Executive | Team |
Ketan Rajesh Jadhav | Finance Associate | Team |
Akshay Rai | Marketing Executive | Team |
Lynette Menezes | Business Development Manager | Team |
Azahuchandraprabhu Perumal | Quality Control Manager | Team |
Dheeraj Sharma | Human Resources Sr. Executive | Team |
Cheshta Jalan | Clinical Research Project Manager & Business Development | Team |
Ananta Wadekar | Bdm- International Business | Team |
Complete people profiles for Spentose
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Spentose
Figures of Swati Spentose Private Limited, the primary company behind Spentose, for FY 2024. Revenue was ₹206 Cr (+11% year on year). Net profit was ₹29.94 Cr (15% margin). EBITDA was ₹48.09 Cr (23% margin). Revenue has grown at a compounded annual rate of +14% over three years and +19% over five years.
- ₹206 CrRevenue · FY 2024 · +11% YoY
- ₹29.94 CrNet profit · 15% margin
- ₹48.09 CrEBITDA · 23% margin
- ₹2.16 CrPaid-up capital
- 409Employees (provident fund records)
- +14%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Swati Spentose Private Limited are on its company page.
Detailed financial statements for Spentose
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Spentose
Spentose has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Spentose
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Spentose
Spentose was founded in 2005.
Spentose is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Spentose has 409 employees.
The primary company behind Spentose, Swati Spentose Private Limited, reported revenue of ₹206 Cr for FY 2024, up 11% year on year.
SWATI Spentose is a global pharmaceutical company headquartered in Mumbai, India, focused on research and innovation in drug development. They produce active pharmaceutical ingredients (APIs) and finished formulations, addressing neglected diseases and serving over 70 countries. With manufacturing facilities in Vapi, Gujarat, they emphasize quality, compliance, and cost-effective solutions through advanced production processes.
Spentose's top competitors include Laurus Labs, Symbiotec and SeQuent.
Spentose offers APIs and Finished Dosage.
Spentose operates through Swati Spentose Private Limited.
The legal entities of Spentose currently have 3 directors, including Manojkumar Rinwa, Pankaj Ram Sharma, Vishal Narayanprasad Jajodia.